Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (r)-3-methyl-4-(4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine
2. Bay 1895344
1. 1876467-74-1
2. Bay-1895344
3. Bay 1895344
4. Bay1895344
5. Bay-1895344 Hcl
6. 7n13ik9lnh
7. (r)-3-methyl-4-(4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine
8. (3r)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
9. (r)-3-methyl-4-(4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine
10. Elimusertib [inn]
11. Unii-7n13ik9lnh
12. Elimusertib [who-dd]
13. Chembl4647810
14. Schembl17501318
15. Schembl21756640
16. Gtpl10354
17. Elimusertib (bay-1895344)
18. Ex-a1662
19. Nsc800525
20. Nsc817275
21. S9864
22. Nsc-800525
23. Nsc-817275
24. Ac-30337
25. Bb178556
26. Bs-15734
27. Hy-101566
28. Cs-0021722
29. A903444
30. 1,7-naphthyridine, 2-((3r)-3-methyl-4-morpholinyl)-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)-
| Molecular Weight | 375.4 g/mol |
|---|---|
| Molecular Formula | C20H21N7O |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 375.18075832 g/mol |
| Monoisotopic Mass | 375.18075832 g/mol |
| Topological Polar Surface Area | 84.8 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 537 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
43
PharmaCompass offers a list of BAY1895344 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right BAY1895344 manufacturer or BAY1895344 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BAY1895344 manufacturer or BAY1895344 supplier.
PharmaCompass also assists you with knowing the BAY1895344 API Price utilized in the formulation of products. BAY1895344 API Price is not always fixed or binding as the BAY1895344 Price is obtained through a variety of data sources. The BAY1895344 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BAY1895344 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BAY1895344, including repackagers and relabelers. The FDA regulates BAY1895344 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BAY1895344 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BAY1895344 supplier is an individual or a company that provides BAY1895344 active pharmaceutical ingredient (API) or BAY1895344 finished formulations upon request. The BAY1895344 suppliers may include BAY1895344 API manufacturers, exporters, distributors and traders.
BAY1895344 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BAY1895344 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BAY1895344 GMP manufacturer or BAY1895344 GMP API supplier for your needs.
A BAY1895344 CoA (Certificate of Analysis) is a formal document that attests to BAY1895344's compliance with BAY1895344 specifications and serves as a tool for batch-level quality control.
BAY1895344 CoA mostly includes findings from lab analyses of a specific batch. For each BAY1895344 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BAY1895344 may be tested according to a variety of international standards, such as European Pharmacopoeia (BAY1895344 EP), BAY1895344 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BAY1895344 USP).
